Cargando…

Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data()()

The ability to accurately predict response and then rigorously optimize a therapeutic regimen on a patient-specific basis, would transform oncology. Toward this end, we have developed an experimental-mathematical framework that integrates quantitative magnetic resonance imaging (MRI) data into a bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarrett, Angela M., Hormuth, David A., Wu, Chengyue, Kazerouni, Anum S., Ekrut, David A., Virostko, John, Sorace, Anna G., DiCarlo, Julie C., Kowalski, Jeanne, Patt, Debra, Goodgame, Boone, Avery, Sarah, Yankeelov, Thomas E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677708/ https://www.ncbi.nlm.nih.gov/pubmed/33197744 http://dx.doi.org/10.1016/j.neo.2020.10.011

Ejemplares similares

Magnetization Transfer MRI of Breast Cancer in the Community Setting: Reproducibility and Preliminary Results in Neoadjuvant Therapy
por: Virostko, John, et al.
Publicado: (2019)

Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting
por: Virostko, John, et al.
Publicado: (2021)

Characterizing Errors in Pharmacokinetic Parameters from Analyzing Quantitative Abbreviated DCE-MRI Data in Breast Cancer
por: Slavkova, Kalina P., et al.
Publicado: (2021)

Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities
por: Jarrett, Angela M., et al.
Publicado: (2020)

Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis
por: Virostko, John, et al.
Publicado: (2017)

Quantifying Tumor Heterogeneity via MRI Habitats to Characterize Microenvironmental Alterations in HER2+ Breast Cancer
por: Kazerouni, Anum S., et al.
Publicado: (2022)

An experimental-mathematical approach to predict tumor cell growth as a function of glucose availability in breast cancer cell lines
por: Yang, Jianchen, et al.
Publicado: (2021)

Comparing mechanism-based and machine learning models for predicting the effects of glucose accessibility on tumor cell proliferation
por: Yang, Jianchen, et al.
Publicado: (2023)

Mathematical modelling of the dynamics of image-informed tumor habitats in a murine model of glioma
por: Slavkova, Kalina P., et al.
Publicado: (2023)

Author Correction: Mathematical modelling of the dynamics of image-informed tumor habitats in a murine model of glioma
por: Slavkova, Kalina P., et al.
Publicado: (2023)

Forecasting tumor and vasculature response dynamics to radiation therapy via image based mathematical modeling
por: Hormuth, David A., et al.
Publicado: (2020)

Experimentally-driven mathematical modeling to improve combination targeted and cytotoxic therapy for HER2+ breast cancer
por: Jarrett, Angela M., et al.
Publicado: (2019)

Integrating Quantitative Assays with Biologically Based Mathematical Modeling for Predictive Oncology
por: Kazerouni, Anum S., et al.
Publicado: (2020)

Towards an Image-Informed Mathematical Model of In Vivo Response to Fractionated Radiation Therapy
por: Hormuth, David A., et al.
Publicado: (2021)

Predictive digital twin for optimizing patient-specific radiotherapy regimens under uncertainty in high-grade gliomas
por: Chaudhuri, Anirban, et al.
Publicado: (2023)

Towards integration of (64)Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer
por: Jarrett, Angela M., et al.
Publicado: (2020)

Biologically-Based Mathematical Modeling of Tumor Vasculature and Angiogenesis via Time-Resolved Imaging Data
por: Hormuth, David A., et al.
Publicado: (2021)

Quantifying the Effects of Combination Trastuzumab and Radiation Therapy in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
por: Bloom, Meghan J., et al.
Publicado: (2022)

Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer
por: Bloom, Meghan J., et al.
Publicado: (2020)

A Multi-Compartment Model of Glioma Response to Fractionated Radiation Therapy Parameterized via Time-Resolved Microscopy Data
por: Liu, Junyan, et al.
Publicado: (2022)

Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer
por: Syed, Anum K., et al.
Publicado: (2018)

Toward Practical Integration of Omic and Imaging Data in Co-Clinical Trials
por: Alkim, Emel, et al.
Publicado: (2023)

Multiparametric Analysis of Longitudinal Quantitative MRI Data to Identify Distinct Tumor Habitats in Preclinical Models of Breast Cancer
por: Syed, Anum K., et al.
Publicado: (2020)

Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation
por: Hormuth, David A., et al.
Publicado: (2021)

Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer
por: Kazerouni, Anum S., et al.
Publicado: (2023)

Stereotactic Vertebroplasty for Spinal Metastases with Multilevel Bilateral Pedicle Fractures: A Technical Note
por: Ziu, Mateo, et al.
Publicado: (2019)

Racial Disparities in Breast Cancer Presentation and Diagnosis in COVID-Era Central Texas
por: Schommer, Lana, et al.
Publicado: (2023)

Patient-specific, mechanistic models of tumor growth incorporating artificial intelligence and big data
por: Lorenzo, Guillermo, et al.
Publicado: (2023)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
por: Wysocka, Olga, et al.
Publicado: (2016)

Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?
por: Logarajah, Shankar, et al.
Publicado: (2022)

Bayesian calibration of a stochastic, multiscale agent-based model for predicting in vitro tumor growth
por: Lima, Ernesto A. B. F., et al.
Publicado: (2021)

Current and Future Trends in Magnetic Resonance Imaging Assessments of the Response of Breast Tumors to Neoadjuvant Chemotherapy
por: Arlinghaus, Lori R., et al.
Publicado: (2010)

The optimal neoadjuvant regimen for nonsmall cell lung cancer: A meta-analysis
por: Liu, Yi, et al.
Publicado: (2022)

Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?
por: Jang, Min Kyeong, et al.
Publicado: (2022)

Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?
por: Zhu, Jiahao, et al.
Publicado: (2023)

Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging Data to Constrain a Positron Emission Tomography Kinetic Model: Theory and Simulations
por: Fluckiger, Jacob U., et al.
Publicado: (2013)

How to do (or not to do)… health resource allocations using constrained mathematical optimization
por: Stuart, Robyn M, et al.
Publicado: (2022)

Constraining the Topology of the Universe
por: Cornish, Neil J., et al.
Publicado: (2003)

CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro
por: Song, Patrick N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_geabduicqbopenlechohvup99s